• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于计算机辅助 PROTAC 设计的方法。

Methods for computer-assisted PROTAC design.

机构信息

Structural Genomics Consortium, University of Toronto, Toronto, ON, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.

Structural Genomics Consortium, University of Toronto, Toronto, ON, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.

出版信息

Methods Enzymol. 2023;690:311-340. doi: 10.1016/bs.mie.2023.06.020. Epub 2023 Jul 21.

DOI:10.1016/bs.mie.2023.06.020
PMID:37858533
Abstract

Proximity-induced pharmacology is an emerging field in chemical biology and drug discovery where a small molecule induces non-natural interactions between two proteins, leading to specific phenotypic responses. Proteolysis targeting chimeras (PROTACs) are the most mature examples, where ligands for an E3 ligase and a target protein are linked to induce the ubiquitination and subsequent degradation of the target. The discovery of PROTACs typically relies on a trial-and-error approach where chemical handles and linker chemistry, length and attachment points are systematically varied in the hope that one of the combinations will produce an active molecule. Novel computational methods and tools are developed in an attempt to rationalize and accelerate this process and differ significantly from traditional structure-based drug design approaches. In this chapter, we review three different solutions for computer-assisted PROTAC design: MOE, ICM and PRosettaC. Specifically, we describe protocols to predict the structure of ternary complexes (E3 ligase-PROTAC-target protein) and to screen virtually libraries of PROTAC candidates. We also provide troubleshooting tips. Rational PROTAC design is still in its infancy. By opening this space to users and developers, we hope that this methods article will contribute to much needed advancement in the field.

摘要

邻近诱导药理学是化学生物学和药物发现领域的一个新兴领域,其中小分子诱导两个蛋白质之间的非天然相互作用,导致特定的表型反应。蛋白水解靶向嵌合体(PROTAC)是最成熟的例子,其中 E3 连接酶和靶蛋白的配体被连接起来,以诱导靶蛋白的泛素化和随后的降解。PROTAC 的发现通常依赖于试错法,其中化学处理和连接化学、长度和连接点被系统地改变,希望其中一种组合将产生一种活性分子。新的计算方法和工具被开发出来,试图合理化和加速这个过程,与传统的基于结构的药物设计方法有很大的不同。在这一章中,我们回顾了三种不同的计算机辅助 PROTAC 设计解决方案:MOE、ICM 和 PRosettaC。具体来说,我们描述了预测三元复合物(E3 连接酶-PROTAC-靶蛋白)结构和虚拟筛选 PROTAC 候选物文库的协议。我们还提供了故障排除技巧。理性的 PROTAC 设计仍处于起步阶段。通过向用户和开发人员开放这个空间,我们希望这篇方法文章将有助于该领域急需的进展。

相似文献

1
Methods for computer-assisted PROTAC design.用于计算机辅助 PROTAC 设计的方法。
Methods Enzymol. 2023;690:311-340. doi: 10.1016/bs.mie.2023.06.020. Epub 2023 Jul 21.
2
Benchmarking Methods for PROTAC Ternary Complex Structure Prediction.用于 PROTAC 三元复合物结构预测的基准测试方法。
J Chem Inf Model. 2024 Aug 12;64(15):6162-6173. doi: 10.1021/acs.jcim.4c00426. Epub 2024 Aug 1.
3
PRosettaC: Rosetta Based Modeling of PROTAC Mediated Ternary Complexes.PRosettaC:基于 Rosetta 的 PROTAC 介导的三元复合物建模。
J Chem Inf Model. 2020 Oct 26;60(10):4894-4903. doi: 10.1021/acs.jcim.0c00589. Epub 2020 Oct 6.
4
Modeling the CRL4A ligase complex to predict target protein ubiquitination induced by cereblon-recruiting PROTACs.基于 CRBN 招募型 PROTAC 预测靶蛋白泛素化的 CRL4A 连接酶复合物建模。
J Biol Chem. 2022 Apr;298(4):101653. doi: 10.1016/j.jbc.2022.101653. Epub 2022 Jan 29.
5
Kinetic Detection of E3:PROTAC:Target Ternary Complexes Using NanoBRET Technology in Live Cells.利用 NanoBRET 技术在活细胞中对 E3:PROTAC:靶标三元复合物进行动力学检测。
Methods Mol Biol. 2021;2365:151-171. doi: 10.1007/978-1-0716-1665-9_8.
6
Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead.从具有混杂弹头的选择性降解中吸取 PROTAC 设计的经验教训。
Cell Chem Biol. 2018 Jan 18;25(1):78-87.e5. doi: 10.1016/j.chembiol.2017.09.010. Epub 2017 Nov 9.
7
High Accuracy Prediction of PROTAC Complex Structures.高精准度的 PROTAC 复合物结构预测。
J Am Chem Soc. 2023 Apr 5;145(13):7123-7135. doi: 10.1021/jacs.2c09387. Epub 2023 Mar 24.
8
E3 ligase ligand chemistries: from building blocks to protein degraders.E3 连接酶配体化学:从构建模块到蛋白质降解剂
Chem Soc Rev. 2022 May 10;51(9):3487-3534. doi: 10.1039/d2cs00148a.
9
Discovery of E3 Ligase Ligands for Target Protein Degradation.E3 连接酶配体用于靶蛋白降解的发现。
Molecules. 2022 Oct 2;27(19):6515. doi: 10.3390/molecules27196515.
10
PROTAC-DB: an online database of PROTACs.PROTAC-DB:一个 PROTAC 数据库。
Nucleic Acids Res. 2021 Jan 8;49(D1):D1381-D1387. doi: 10.1093/nar/gkaa807.

引用本文的文献

1
PROTAC-Based Antivirals for Respiratory Viruses: A Novel Approach for Targeted Therapy and Vaccine Development.基于PROTAC的呼吸道病毒抗病毒药物:靶向治疗和疫苗开发的新方法
Microorganisms. 2025 Jul 2;13(7):1557. doi: 10.3390/microorganisms13071557.
2
Molecular Design of Novel Protein-Degrading Therapeutics Agents Currently in Clinical Trial.目前正在临床试验的新型蛋白质降解治疗药物的分子设计。
Pharmaceutics. 2025 Jun 5;17(6):744. doi: 10.3390/pharmaceutics17060744.
3
HaloPROTAC3 does not trigger the degradation of the halotagged parasitophorous vacuole membrane protein UIS4 during Plasmodium liver stage development.
在疟原虫肝脏期发育过程中,HaloPROTAC3不会引发带有卤化物标签的寄生泡膜蛋白UIS4的降解。
Sci Rep. 2025 May 26;15(1):18323. doi: 10.1038/s41598-025-98257-9.
4
Targeted degradation of extracellular proteins: state of the art and diversity of degrader designs.细胞外蛋白质的靶向降解:最新进展与降解剂设计的多样性
J Hematol Oncol. 2025 May 1;18(1):52. doi: 10.1186/s13045-025-01703-4.
5
Ternary Complex Modeling, Induced Fit Docking and Molecular Dynamics Simulations as a Successful Approach for the Design of VHL-Mediated PROTACs Targeting the Kinase FLT3.三元复合物建模、诱导契合对接和分子动力学模拟作为设计靶向激酶FLT3的VHL介导的PROTAC的成功方法。
Arch Pharm (Weinheim). 2025 Apr;358(4):e3126. doi: 10.1002/ardp.202500102.
6
Application of a bivalent "click" approach to target tyrosyl-DNA phosphodiesterase 1 (TDP1).一种用于靶向酪氨酰-DNA磷酸二酯酶1(TDP1)的双价“点击”方法的应用。
RSC Med Chem. 2025 Feb 21;16(5):1969-1985. doi: 10.1039/d4md00824c. eCollection 2025 May 22.